Vanguard Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $88.1B | Buy |
81,965,974
+1,006,885
| +1% | +$963M | 1.28% | 10 |
|
|
2025
Q3 | $61.8B | Buy |
80,959,089
+551,659
| +0.7% | +$411M | 0.92% | 12 |
|
|
2025
Q2 | $62.7B | Buy |
80,407,430
+1,183,038
| +1% | +$919M | 1.01% | 12 |
|
|
2025
Q1 | $65.4B | Buy |
79,224,392
+4,975,395
| +7% | +$4.14B | 1.18% | 10 |
|
|
2024
Q4 | $57.3B | Buy |
74,248,997
+475,530
| +0.6% | +$394M | 1% | 12 |
|
|
2024
Q3 | $65.4B | Sell |
73,773,467
-85,541
| -0.1% | -$76.9M | 1.17% | 10 |
|
|
2024
Q2 | $66.9B | Buy |
73,859,008
+1,113,997
| +2% | +$891M | 1.28% | 9 |
|
|
2024
Q1 | $56.6B | Buy |
72,745,011
+1,133,810
| +2% | +$807M | 1.12% | 10 |
|
|
2023
Q4 | $41.7B | Buy |
71,611,201
+1,035,599
| +1% | +$604M | 0.91% | 13 |
|
|
2023
Q3 | $37.9B | Buy |
70,575,602
+659,838
| +0.9% | +$340M | 0.93% | 13 |
|
|
2023
Q2 | $32.8B | Sell |
69,915,764
-81,618
| -0.1% | -$34.2M | 0.78% | 17 |
|
|
2023
Q1 | $24B | Sell |
69,997,382
-3,432,481
| -5% | -$1.16B | 0.61% | 22 |
|
|
2022
Q4 | $26.9B | Buy |
73,429,863
+841,546
| +1% | +$298M | 0.73% | 17 |
|
|
2022
Q3 | $23.5B | Buy |
72,588,317
+996,990
| +1% | +$316M | 0.69% | 17 |
|
|
2022
Q2 | $23.2B | Buy |
71,591,327
+1,110,149
| +2% | +$333M | 0.65% | 21 |
|
|
2022
Q1 | $20.2B | Buy |
70,481,178
+1,219,424
| +2% | +$314M | 0.48% | 27 |
|
|
2021
Q4 | $19.1B | Buy |
69,261,754
+218,594
| +0.3% | +$55.4M | 0.43% | 35 |
|
|
2021
Q3 | $16B | Buy |
69,043,160
+73,612
| +0.1% | +$18.2M | 0.4% | 39 |
|
|
2021
Q2 | $15.8B | Sell |
68,969,548
-317,415
| -0.5% | -$63.8M | 0.39% | 41 |
|
|
2021
Q1 | $12.9B | Buy |
69,286,963
+625,469
| +0.9% | +$122M | 0.35% | 48 |
|
|
2020
Q4 | $11.6B | Sell |
68,661,494
-503,870
| -0.7% | -$75.2M | 0.34% | 51 |
|
|
2020
Q3 | $10.2B | Sell |
69,165,364
-2,439,723
| -3% | -$378M | 0.34% | 56 |
|
|
2020
Q2 | $11.8B | Sell |
71,605,087
-1,070,561
| -1% | -$164M | 0.42% | 41 |
|
|
2020
Q1 | $10.1B | Buy |
72,675,648
+1,755,598
| +2% | +$241M | 0.43% | 40 |
|
|
2019
Q4 | $9.32B | Sell |
70,920,050
-45,200
| -0.1% | -$5.24M | 0.32% | 58 |
|
|
2019
Q3 | $7.94B | Sell |
70,965,250
-169,128
| -0.2% | -$18.8M | 0.29% | 61 |
|
|
2019
Q2 | $7.88B | Buy |
71,134,378
+578,045
| +0.8% | +$68.1M | 0.3% | 57 |
|
|
2019
Q1 | $9.16B | Sell |
70,556,333
-5,101,886
| -7% | -$620M | 0.36% | 48 |
|
|
2018
Q4 | $8.76B | Buy |
75,658,219
+1,525,234
| +2% | +$170M | 0.39% | 41 |
|
|
2018
Q3 | $7.96B | Buy |
74,132,985
+511,752
| +0.7% | +$51.2M | 0.31% | 57 |
|
|
2018
Q2 | $6.28B | Buy |
73,621,233
+585,843
| +0.8% | +$48.1M | 0.26% | 66 |
|
|
2018
Q1 | $5.65B | Buy |
73,035,390
+812,993
| +1% | +$65.4M | 0.25% | 69 |
|
|
2017
Q4 | $6.1B | Buy |
72,222,397
+917,021
| +1% | +$78M | 0.27% | 61 |
|
|
2017
Q3 | $6.1B | Buy |
71,305,376
+1,097,485
| +2% | +$90M | 0.29% | 58 |
|
|
2017
Q2 | $5.78B | Buy |
70,207,891
+1,610,885
| +2% | +$131M | 0.28% | 58 |
|
|
2017
Q1 | $5.77B | Buy |
68,597,006
+2,181,701
| +3% | +$175M | 0.3% | 54 |
|
|
2016
Q4 | $4.88B | Buy |
66,415,305
+1,470,123
| +2% | +$109M | 0.27% | 61 |
|
|
2016
Q3 | $5.21B | Buy |
64,945,182
+1,708,505
| +3% | +$137M | 0.31% | 52 |
|
|
2016
Q2 | $4.98B | Buy |
63,236,677
+1,350,329
| +2% | +$102M | 0.31% | 53 |
|
|
2016
Q1 | $4.46B | Buy |
61,886,348
+1,973,169
| +3% | +$149M | 0.29% | 60 |
|
|
2015
Q4 | $5.05B | Buy |
59,913,179
+1,552,428
| +3% | +$129M | 0.34% | 51 |
|
|
2015
Q3 | $4.88B | Buy |
58,360,751
+892,283
| +2% | +$75.3M | 0.35% | 50 |
|
|
2015
Q2 | $4.8B | Buy |
57,468,468
+697,084
| +1% | +$53.1M | 0.32% | 51 |
|
|
2015
Q1 | $4.12B | Buy |
56,771,384
+2,042,825
| +4% | +$145M | 0.28% | 61 |
|
|
2014
Q4 | $3.78B | Buy |
54,728,559
+1,731,599
| +3% | +$117M | 0.27% | 65 |
|
|
2014
Q3 | $3.44B | Buy |
52,996,960
+1,036,766
| +2% | +$65.6M | 0.27% | 64 |
|
|
2014
Q2 | $3.23B | Buy |
51,960,194
+778,619
| +2% | +$46.5M | 0.25% | 67 |
|
|
2014
Q1 | $3.01B | Buy |
51,181,575
+1,056,459
| +2% | +$59M | 0.25% | 71 |
|
|
2013
Q4 | $2.56B | Buy |
50,125,116
+719,465
| +1% | +$36M | 0.22% | 81 |
|
|
2013
Q3 | $2.49B | Buy |
49,405,651
+1,065,947
| +2% | +$55.8M | 0.24% | 77 |
|
|
2013
Q2 | $2.37B | Buy |
+48,339,704
| New | +$2.63B | 0.25% | 71 |
|
Other funds holding LLY
Vanguard Group's LLY Position: Q4 2025 in Review
Vanguard Group increased its Eli Lilly (LLY) stake by 1.2% in Q4 2025, buying an estimated $963M and bringing the position to 81,965,974 shares worth $88.1B. The position accounts for 1.28% of the portfolio, ranked #10.
Vanguard Group first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Vanguard Group held 81,965,974 shares of Eli Lilly worth $88.1B as of Q4 2025.
- Vanguard Group bought 1,006,885 Eli Lilly shares in Q4 2025, an estimated $963M.
- Eli Lilly made up 1.28% of Vanguard Group's portfolio in Q4 2025, its #10 holding.
- Vanguard Group first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.